- •PROGRESS IN BRAIN RESEARCH
- •List of Contributors
- •Preface
- •Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects
- •Introduction
- •Prevalence of glaucoma
- •PAC suspect
- •PACG
- •Incidence of glaucoma
- •Blinding effects of glaucoma
- •Abbreviations
- •Acknowledgment
- •References
- •Predictive models to estimate the risk of glaucoma development and progression
- •Risk assessment in ocular hypertension and glaucoma
- •Risk factors for glaucoma development
- •Intraocular pressure
- •Corneal thickness
- •Cup/disc ratio and pattern standard deviation
- •The need for predictive models
- •Predictive models for glaucoma development
- •Predictive models for glaucoma progression
- •Limitations of predictive models
- •References
- •Intraocular pressure and central corneal thickness
- •Main text
- •References
- •Angle-closure: risk factors, diagnosis and treatment
- •Introduction
- •Mechanism
- •Other causes of angle closure
- •Risk factors
- •Age and gender
- •Ethnicity
- •Ocular biometry
- •Genetics
- •Diagnosis
- •Acute primary angle closure
- •Angle assessment in angle closure
- •Gonioscopy technique
- •Ultrasound biomicroscopy (UBM)
- •Scanning peripheral anterior chamber depth analyzer (SPAC)
- •Management
- •Acute primary angle closure
- •Medical therapy
- •Argon laser peripheral iridoplasty (ALPI)
- •Laser peripheral iridotomy (PI)
- •Lens extraction
- •Monitoring for subsequent IOP rise in eyes with APAC
- •Fellow eye of APAC
- •Chronic primary angle-closure glaucoma (CACG)
- •Laser peripheral iridotomy
- •Laser iridoplasty
- •Medical therapy
- •Trabeculectomy
- •Lens extraction
- •Combined lens extraction and trabeculectomy surgery
- •Goniosynechialysis
- •Summary
- •List of abbreviations
- •References
- •Early diagnosis in glaucoma
- •Introduction
- •History and examination
- •Quantitative tests and the diagnostic process
- •Pretest probability
- •Test validity
- •Diagnostic test performance
- •Posttest probability
- •Combing test results
- •Selective tests of visual function
- •Early glaucoma diagnosis from quantitative test results
- •Progression to make a diagnosis
- •Conclusions
- •Abbreviations
- •References
- •Monitoring glaucoma progression
- •Introduction
- •Monitoring structural damage progression
- •Monitoring functional damage progression
- •Abbreviations
- •References
- •Standard automated perimetry and algorithms for monitoring glaucoma progression
- •Standard automated perimetry
- •Global indices
- •HFA: MD, SF, PSD, CPSD
- •Octopus indices: MD, SF, CLV
- •OCTOPUS seven-in-one report (Fig. 2)
- •SAP VF assessment: full-threshold strategy
- •SAP VF defects assessment: OHTS criteria
- •SAP VF defects assessment: AGIS criteria
- •SAP VF defects assessment: CIGTS
- •Fastpac
- •Swedish interactive threshold algorithm
- •SAP VF assessment: the glaucoma staging system
- •SAP: interocular asymmetries in OHTS
- •SAP, VF progression
- •SAP: the relationship to other functional and structural diagnostic tests in glaucoma
- •SAP, FDP-Matrix
- •SAP, SWAP, HPRP, FDT
- •SAP: the relationship between function and structure
- •SAP, confocal scanning laser ophthalmoscopy, SLP-VCC
- •SAP, optical coherence tomography
- •SAP and functional magnetic resonance imaging
- •References
- •Introduction
- •Retinal ganglion cells: anatomy and function
- •Is glaucoma damage selective for any subgroup of RGCs?
- •Segregation
- •Isolation
- •FDT: rationale and perimetric techniques
- •SWAP: rationale and perimetric techniques
- •FDT: clinical data
- •SWAP: clinical data
- •Clinical data comparing FDT and SWAP
- •Conclusions
- •References
- •Scanning laser polarimetry and confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma
- •The GDx scanning laser polarimeter
- •Serial analysis
- •Limits
- •The Heidelberg retinal tomograph
- •Limits
- •Conclusions
- •References
- •The role of OCT in glaucoma management
- •Introduction
- •How OCT works
- •How OCT is performed
- •Evaluation of RNFL thickness
- •Evaluation of optic disc
- •OCT in glaucoma management
- •New perspective
- •Abbreviations
- •References
- •Introduction
- •Technology
- •Visual stimulation
- •Reproducibility and habituation of RFonh
- •Retinal neural activity as assessed from the electroretinogram (ERG)
- •The Parvo (P)- and Magno (M)-cellular pathways
- •Physiology
- •Magnitude and time course of RFonh in humans
- •Varying the parameters of the stimulus on RFonh
- •Luminance versus chromatic modulation
- •Frequency
- •Effect of pattern stimulation
- •Neurovascular coupling in humans
- •Clinical application
- •RFonh in OHT and glaucoma patients
- •Discussion
- •FLDF and neurovascular coupling in humans
- •Comments on clinical application of FLDF in glaucoma
- •Conclusions and futures directions
- •Acknowledgements
- •References
- •Advances in neuroimaging of the visual pathways and their use in glaucoma
- •Introduction
- •Conventional MR imaging and the visual pathways
- •Diffusion MR imaging
- •Functional MR imaging
- •Proton MR spectroscopy
- •References
- •Primary open angle glaucoma: an overview on medical therapy
- •Introduction
- •When to treat
- •Whom to treat
- •Genetics
- •Race
- •Ocular and systemic abnormalities
- •Tonometry and pachymetry
- •How to treat
- •Beta-blockers
- •Prostaglandins
- •Alpha-agonists
- •Carbonic anhydrase inhibitors (CAIs)
- •Myotics
- •Fixed combinations
- •References
- •The treatment of normal-tension glaucoma
- •Introduction
- •Epidemiology
- •Clinical features
- •Optic disk
- •Central corneal thickness
- •Disease course
- •Risk factors
- •Intraocular pressure
- •Local vascular factors
- •Immune mechanisms
- •Differential diagnosis
- •Diagnostic evaluation
- •Therapy
- •IOP reduction
- •Systemic medications
- •Neuroprotection
- •Noncompliance
- •Genetics of NTG
- •Abbreviations
- •References
- •The management of exfoliative glaucoma
- •Introduction
- •Epidemiology
- •Ocular and systemic associations
- •Ocular associations
- •Systemic associations
- •Pathogenesis of exfoliation syndrome
- •Mechanisms of glaucoma development
- •Management
- •Medical therapy
- •Laser surgery
- •Operative surgery
- •Future treatment of exfoliation syndrome and exfoliative glaucoma
- •Treatment directed at exfoliation material
- •References
- •Laser therapies for glaucoma: new frontiers
- •Background
- •Laser iridotomy
- •Indications
- •Contraindications
- •Patient preparation
- •Technique
- •Nd:YAG laser iridectomy
- •Argon laser iridectomy
- •Complications
- •LASER trabeculoplasty
- •Treatment technique
- •Mechanism of action
- •Indications for treatment
- •Contraindications to treatment
- •Patient preparation and postoperative follow-up
- •Complications of the treatment
- •Selective laser trabeculoplasty
- •Results
- •LASER iridoplasty
- •Indications
- •Contraindications
- •Treatment technique
- •Complications
- •LASER cyclophotocoagulation
- •Introduction
- •Indications and contraindications
- •Patient preparation
- •Transpupillary cyclophotocoagulation
- •Endoscopic cyclophotocoagulation
- •Transscleral cyclophotocoagulation
- •Transscleral noncontact cyclophotocoagulation
- •Transscleral contact cyclophotocoagulation
- •Complications
- •Excimer laser trabeculotomy
- •References
- •Modulation of wound healing during and after glaucoma surgery
- •The process of wound healing
- •Using surgical and anatomical principles to modify therapy
- •Growth factors
- •Cellular proliferation and vascularization
- •Cell motility, matrix contraction and synthesis
- •Drug delivery
- •Future directions: total scarring control and tissue regeneration
- •Acknowledgments
- •References
- •Surgical alternative to trabeculectomy
- •Introduction
- •Deep sclerectomy
- •Viscocanalostomy
- •Conclusions
- •References
- •Modern aqueous shunt implantation: future challenges
- •Background
- •Current shunts and factors affecting their function
- •Shunt-related factors
- •Surface area
- •Plate material
- •Valved versus non-valved
- •Commercially available devices
- •Comparative studies
- •Patient and ocular factors
- •Severity of glaucoma damage
- •Tolerance of topical ocular hypotensive medications
- •Aqueous hyposecretion
- •Previous ocular surgery
- •Scleral thinning
- •Patient cooperation for and tolerance of potential slit-lamp interventions
- •Future challenges
- •Predictability
- •Cataract formation
- •The long-term effect on the cornea
- •References
- •Model systems for experimental studies: retinal ganglion cells in culture
- •Mixed RGCs in culture
- •Retinal explants
- •Glial cultures
- •RGC-5 cells
- •Differentiation of RGC-5 cells
- •RGC-5 cell neurites
- •Advantages and disadvantages of culture models
- •References
- •Rat models for glaucoma research
- •Rat models for glaucoma research
- •Use of animal models for POAG
- •Suitability of the rat for models of optic nerve damage in POAG
- •Methods for measuring IOP in rats
- •General considerations for measuring IOP in rats
- •Assessing optic nerve and retina damage
- •Experimental methods of producing elevated IOP
- •Laser treatment of limbal tissues
- •Episcleral vein cautery
- •Conclusions
- •Abbreviations
- •Acknowledgements
- •References
- •Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection
- •Introduction
- •The mouse as a model system
- •Mice are suitable models for studying IOP elevation in glaucoma
- •Tools for glaucoma research
- •Accurate IOP measurements are fundamental to the study of glaucoma
- •The future of IOP assessment
- •Assessment of RGC function
- •Mouse models of glaucoma
- •Primary open-angle glaucoma
- •MYOC
- •OPTN
- •Strategies for developing new models of POAG
- •Developmental glaucoma
- •Pigmentary glaucoma
- •Experimentally induced models of glaucoma
- •Mouse models to characterize processes involved in glaucomatous neurodegeneration
- •Similar patterns of glaucomatous damage occur in humans and mice
- •The lamina cribrosa is an important site of early glaucomatous damage
- •An insult occurs to the axons of RGCs within the lamina in glaucoma
- •What is the nature of the insult at the lamina?
- •Other changes occur in the retina in glaucoma
- •PERG and complement
- •Using mouse models to develop neuroprotective strategies
- •Somal protection
- •Axonal protection
- •Erythropoietin administration
- •Radiation-based treatment
- •References
- •Clinical trials in neuroprotection
- •Introduction
- •Methods of clinical studies
- •Issues in the design and conduct of clinical trials
- •Clinical trials of neuroprotection
- •Clinical trials of neuroprotection in ophthalmology
- •Endpoints
- •Neuroprotection and glaucoma
- •Conclusions
- •Abbreviations
- •References
- •Pathogenesis of ganglion ‘‘cell death’’ in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria
- •Introduction
- •Retinal ganglion cells and mitochondria
- •Possible causes for ganglion cell death in glaucoma
- •Mitochondrial functions and apoptosis
- •Mitochondrial function enhancement and the attenuation of ganglion cell death
- •Creatine
- •Nicotinamide
- •Epigallocatechin gallate
- •Conclusion
- •References
- •Astrocytes in glaucomatous optic neuropathy
- •Introduction
- •Quiescent astrocytes
- •Reactive astrocytes in glaucoma
- •Signal transduction in glaucomatous astrocytes
- •Protein tyrosine kinases (PTKs)
- •Serine/threonine protein mitogen-activated kinases (MAPKs)
- •G protein-coupled receptors
- •Ras superfamily of small G proteins
- •Astrocyte migration in the glaucomatous optic nerve head
- •Cell adhesion of ONH astrocytes
- •Connective tissue changes in the glaucomatous optic nerve head
- •Extracellular matrix synthesis by ONH astrocytes
- •Extracellular matrix degradation by reactive astrocytes
- •Oxidative stress in ONH astrocytes
- •Conclusions
- •Acknowledgments
- •References
- •Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation
- •Glaucoma as a neurodegenerative disease
- •Oxidative stress and free radicals
- •Excessive glutamate, increased calcium levels, and excitotoxicity
- •Deprivation of neurotrophins and growth factors
- •Abnormal accumulation of proteins
- •Pharmacological neuroprotection for glaucoma
- •Protection of the retinal ganglion cells involves the immune system
- •Searching for an antigen for potential glaucoma therapy
- •Concluding remarks
- •References
- •Oxidative stress and glaucoma: injury in the anterior segment of the eye
- •Introduction
- •Oxidative stress
- •Trabecular meshwork
- •IOP increase and free radicals
- •Glaucomatous cascade
- •Nitric oxide and endothelins
- •Extracellular matrix
- •Metalloproteinases
- •Other factors of interest
- •Therapeutic and preventive substances of interest in glaucoma
- •Ginkgo biloba extract
- •Green tea
- •Ginseng
- •Memantine and its derivates
- •Conclusions
- •Abbreviations
- •References
- •Conclusions on neuroprotective treatment targets in glaucoma
- •Acknowledgments
- •References
- •Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death
- •Introduction
- •Intrinsic apoptosis vs. extrinsic apoptosis
- •The Bcl2 family of proteins
- •The requirement of BAX for RGC soma death
- •BH3-only proteins and the early signaling of ganglion cell apoptosis
- •Conclusion
- •Abbreviations
- •Acknowledgments
- •References
- •Assessment of neuroprotection in the retina with DARC
- •Introduction
- •DARC
- •Introducing the DARC technique
- •Annexin 5-labeled apoptosis and ophthalmoloscopy
- •Detection of RGC apoptosis in glaucoma-related animal models with DARC
- •Assessment of glutamate modulation with DARC
- •Glutamate at synaptic endings
- •Glutamate excitotoxicity in glaucoma
- •Assessment of coenzyme Q10 in glaucoma-related models with DARC
- •Summary
- •Abbreviations
- •Acknowledgment
- •References
- •Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection
- •Introduction
- •The endocannabinoid system in the eye
- •The IOP-lowering effects of endocannabinoids
- •Endocannabinoids and neuroprotection
- •Conclusions
- •References
- •Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration
- •Retinal ganglion cells, retino-geniculate neurons
- •Lateral geniculate nucleus
- •Mechanisms of RGC injury in glaucoma
- •Transsynaptic degeneration of the lateral geniculate nucleus in glaucoma
- •Neural degeneration in magno-, parvo-, and koniocellular LGN layers
- •Visual cortex in glaucoma
- •Neuropathology of glaucoma in the visual pathways in the human brain
- •Mechanisms of glaucoma damage in the central visual pathways
- •Implications of central visual system injury in glaucoma
- •Conclusion
- •Acknowledgments
- •References
- •Clinical relevance of optic neuropathy
- •Is there a remodeling of retinal circuitry?
- •Behavioral consequences of glaucoma
- •Glaucoma as a neurodegenerative disease versus neuroplasticity and adaptive changes
- •Future directions
- •Acknowledgment
- •References
- •Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma
- •Introduction
- •Channel properties of NMDA receptors correlated with excitotoxicity
- •Downstream signaling cascades after overactivation of NMDA receptors
- •Relevance of excitotoxicity to glaucoma
- •Therapeutic approaches to prevent RGC death by targeting the pathways involved in NMDA excitotoxicity
- •Drugs targeting NMDA receptors
- •Kinetics of NMDA receptor antagonists
- •Memantine
- •NitroMemantines
- •Drugs targeting downstream signaling molecules in NMDA-induced cell death pathways
- •p38 MAPK inhibitors
- •Averting caspase-mediated neurodegeneration
- •Abbreviations
- •Acknowledgments
- •References
- •Stem cells for neuroprotection in glaucoma
- •Introduction
- •Glaucoma as a model of neurodegenerative disease
- •Why use stem cells for neuroprotective therapy?
- •Stem cell sources
- •Neuroprotection by transplanted stem cells
- •Endogenous stem cells
- •Key challenges
- •Conclusion
- •Abbreviations
- •Acknowledgments
- •References
- •The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells
- •Introduction
- •Glaucoma and the RGCs
- •Are other retinal cells affected in glaucoma?
- •Retinal ischemia related glaucoma
- •Excitotoxicity and the retina
- •Signal transduction
- •NMDA receptor antagonists and CaMKII
- •Caspase-3 activation in NMDA-induced retinal cell death and its inhibition by m-AIP
- •BDNF and neuroprotection of RGCs
- •Summary and conclusions
- •Abbreviations
- •Acknowledgments
- •References
- •Evidence of the neuroprotective role of citicoline in glaucoma patients
- •Introduction
- •Patients: selection and recruitment criteria
- •Pharmacological treatment protocol
- •Methodology of visual function evaluation: electrophysiological examinations
- •PERG recordings
- •VEP recordings
- •Statistic evaluation of electrophysiological results
- •Electrophysiological (PERG and VEP) responses in OAG patients after the second period of evaluation
- •Effects of citicoline on retinal function in glaucoma patients: neurophysiological implications
- •Effects of citicoline on neural conduction along the visual pathways in glaucoma patients: neurophysiological implications
- •Possibility of neuroprotective role of citicoline in glaucoma patients
- •Conclusive remarks
- •Abbreviations
- •References
- •Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon
- •Neuroprotection: VEGF-A, a shared growth factor
- •VEGF-A isoforms
- •VEGF-A receptors
- •Angiogenesis, mitogenesis, and endothelial survival
- •Neurotrophic and neuroprotective effect
- •Intravitreal VEGF inhibition therapy and neuroretina toxicity
- •Neuroprotection: clusterin, a multifunctional protein
- •Clusterin/ApoJ: a debated physiological role
- •Clusterin and diseases
- •Clusterin and the nervous system
- •Neuroprotection: IL-6, VEGF, clusterin, and glaucoma
- •Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection
- •Introduction
- •Ischemia model
- •Neuroprotective effect of Coenzyme Q10 against cell loss yielded by transient ischemia in the RGC layer
- •Retinal ischemia and glutamate
- •Coenzyme Q10 minimizes glutamate increase induced by ischemia/reperfusion
- •Summary
- •Acknowledgment
- •References
- •17beta-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat
- •Methods
- •Morphometric analysis
- •Microdialysis
- •Drug application
- •Statistical analysis
- •Results
- •17beta-Estradiol pretreatment minimizes RGC loss
- •Discussion
- •Acknowledgment
Combined lens extraction and trabeculectomy surgery
Combined lens extraction and filtration surgery also has a role in the management of CACG. This allows for visual rehabilitation after cataract extraction, prevention of IOP spikes in the immediate post-operative period, and widening of the angle after lens removal with improved IOP control. A retrospective study from Singapore showed that combined phacoemulisfication with posterior chamber intraocular lens implantation and trabeculectomy was associated with good IOP control and visual outcome in patients with PACG (Aung, 2006). Another study found the complication rates of phacotrabeculectomy were similar in PACG and POAG (Aung, 2006).
Goniosynechialysis
This procedure involves the stripping of PAS from the angle wall, therefore opening the angle and restoring trabecular function. It is another surgical option for the treatment of CACG and is more effective if the synechiae have been present for less than a year (Aung, 2006).
Summary
In summary, angle-closure glaucoma is usually an aggressive, visually destructive disease. By assessing the risk factors and diagnosing the mechanism involved in a patient’s condition, the management of that patient can be tailored appropriately.
List of abbreviations
ACD |
anterior chamber depth |
ALPI |
argon laser peripheral iridoplasty |
APAC |
acute primary angle closure |
AS-OCT |
anterior segment optical coherence |
|
tomography |
CACG |
chronic primary angle-closure |
|
glaucoma |
ggrams
43
GON |
glaucomatous optic neuropathy |
IOP |
intraocular pressure |
kg |
kilograms |
mg |
milligrams |
mmHg |
millimeters of mercury |
MMP-9 |
matrix metallopeptidase 9 |
mW |
illiwatts |
MYOC |
myocilin gene |
Nd:YAG |
neodyuim:yttrium-aluminum- |
|
garnet |
PAC |
primary angle closure |
PACG |
primary closed angle glaucoma |
PACS |
primary angle-closure suspect |
PAS |
peripheral anterior synechiae |
PI |
laser peripheral iridotomy |
POAG |
primary open angle glaucoma |
sseconds
SPAC |
scanning peripheral anterior |
|
chamber depth analyzer |
UBM |
ultrasound biomicroscopy |
%percent
mm micrometers
References
Alsagoff, Z., Aung, T., Ang, L.P. and Chew, P.T. (2000) Longterm clinical course of primary angle-closure glaucoma in an Asian population. Ophthalmology, 107: 2300–2304.
Alsbirk, P.H. (1974) Anterior chamber depth in Greenland Eskimos. A population study of variation with age and sex. Acta Ophthalmol. (Copenh.), 52: 551–564.
Alsbirk, P.H. (1975) Anterior chamber depth and primary angle-closure glaucoma. II. A genetic study. Acta Ophthalmol. (Copenh.), 53: 436–449.
Alsbirk, P.H. (1976) Primary angle-closure glaucoma. Oculometry, epidemiology, and genetics in a high-risk population. Acta Ophthalmol. (Copenh.), 54: 5–31.
Arkell, S.M., Lightman, D.A., Sommer, A., et al. (1987) The prevalence of glaucoma among Eskimos of Northwest Alaska. Arch. Ophthalmol., 105: 482–485.
Aung, T. (2006) In: Weinreb R.N. and Friedman D.S. (Eds.), Angle Closure and Angle Closure Glaucoma Consensus Series 3. Kugler Publications.
Aung, T., Ang, L.P., Chan, S.P. and Chew, P.T. (2001) Acute primary angle closure: long-term intraocular pressure outcome in Asian eyes. Am. J. Ophthalmol., 131: 7–12.
Aung, T., Nolan, W.P., Machin, D., et al. (2005a) Anterior chamber depth and the risk of primary angle closure in 2 East Asian populations. Arch. Ophthalmol., 123: 527–532.
Aung, T., Yong, V.H.K., Chew, P.T.K., et al. (2005b) Molecular analysis of the Myocilin gene in Chinese subjects
44
with chronic primary-angle closure glaucoma. Invest. Ophthalmol. Vis. Sci., 46: 1303–1306.
Aung, T., Wong, H.T., Yip, C.C., et al. (2000) Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle-closure glaucoma: a preliminary study. Ophthalmology, 107: 1178–1183.
Baskaran, M. (2006) In: Weinreb R.N. and Friedman D.S. (Eds.), Angle closure and angle closure glaucoma Consensus series 3. Kugler Publications Appendix C.
Baskaran, M., Oen, F.T., Chan, Y.H., et al. (2007) Comparison of the scanning peripheral anterior chamber depth analyzer and the modified van Herick grading system in the assessment of angle closure. Ophthalmology, 114: 501–506.
Becker, R. and Shaffer, R.N. (1965) Diagnosis and Therapy of the Glaucomas. CV Mosby, St. Louis, pp. 42–53.
Buhrmann, R.R., Quigley, H.A., Barron, Y., et al. (2000) Prevalence of glaucoma in a rural East African population. Invest Ophthalmol. Vis. Sci., 41: 40–48.
Chen, T.C., Ang, R.T., Grosskreutz, C.L., et al. (2001) Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery. Ophthalmology, 108: 1033–1038.
Chew, P.T., Aung, T., Aquino, M.V. and Rojanapongpun, P.EXACT Study Group. (2004) Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma. Ophthalmology, 111: 427–434.
Choong, Y.F., Irfan, S. and Manage, M.J. (1999) Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. Eye, 13: 613–616.
Coffey, M., Reidy, A., Wormald, R., et al. (1993) Prevalence of glaucoma in west of Ireland. Br. J. Ophthalmol., 77: 17–21.
Congdon, N., Quigley, H.A., Hung, P.T., et al. (1996) Screening techniques for angle-closure in rural Taiwan. Acta Ophthalmol. Scand., 74: 113–119.
Dandona, L., Dandona, R., Mandal, P., et al. (2000) Angle closure glaucoma in an urban population in Southern India. The Andhra Pradesh Eye Disease Study. Ophthalmology, 107: 1710–1716.
Faucher, M., Anctil, J.L., Rodrigue, M.A., et al. (2002) Founder TIGR/MYOC mutations for glaucoma in the Quebec population. Hum. Mol. Genet., 11: 2077–2090.
Foster, P.J., Alsbirk, P.H., Baasanhu, J., et al. (1997) Anterior chamber depth in Mongolians. Variation with age, sex and method of measurement. Am. J. Ophthalmol., 124: 40–53.
Foster, P.J., Bassanhu, J., Alsbrik, P.H., et al. (1996) Glaucoma in Mongolia. A population based-survey in Hovsgol Province, northern Mongolia. Arch. Ophthalmol., 114: 1235–1241.
Foster, P.J., Buhrmann, R., Quigley, H.A. and Johnson, G.J. (2002) The definition and classification of glaucoma in prevalence surveys. Br. J. Ophthalmol., 238–242.
Foster, P.J. and Johnson, G.J. (2001) Glaucoma in China. How big is the problem? Br. J. Ophthalmol., 85: 1277–1282.
Foster, P.J., Oen, F.T., Machin, D., et al. (2000) The prevalence of glaucoma in Chinese residents of Singapore: a cross sectional population survey of the Tanjong Pagar district. Arch. Ophthalmol., 118: 1105–1111.
Foster, P., He, M. and Liebmann, J. (2006) In: Weinreb R.N. and Friedman D.S. (Eds.), Angle Closure and Angle Closure Glaucoma Consensus Series 3. Kugler Publications, p. 20.
Friedman, D.S., Gazzard, G., Foster, P.J., et al. (2003) Ultrasonograghic biomicroscopy, Scheimpflug photography, and novel provocative tests in contralateral eyes of Chinese patients initially see with acute angle closure. Arch. Ophthalmol., 121: 633–642.
Gazzard, G., Foster, P.J., Viswanathan, A.C., et al. (2002) The severity and spatial distribution of visual field defects in primary glaucoma: a comparison of primary open-angle glaucoma and primary angle-closure glaucoma. Arch. Ophthalmol., 120: 1636–1643.
George, R., Paul, P.G., Baskaran, M., et al. (2003) Ocular biometry in occludable angles and angle closure glaucoma: a population based survey. Br. J. Ophthalmol., 87: 399–402.
He, M., Foster, P.J., Johnson, G.J. and Khaw, P.T. (2006) Angle-closure glaucoma in East Asian and European people. Different diseases? Eye, 20: 3–12.
He, M., Wang, D., Zheng, Y., et al. (2008) Heritability of anterior chamber depth as an intermediate phenotype of angle-closure in Chinese: The Guangzhou Twin Eye Study. Invest Ophthalmol. Vis. Sci., 49: 81–86.
Hollows, F.C. and Graham, P.A. (1966) Intraocular pressure, glaucoma and glaucoma suspects in a defined population. Br. J. Ophthalmol., 50: 570–586.
Ivanisevic, M., Erceg, M., Smoljanovic, A. and Trosic, Z. (2002) Incidence and seasonal variations of acute primary angle-closure glaucoma. Coll. Antropol., 26: 41–45.
Jacob, A., Thomas, R., Koshi, S.P., et al. (1998) Prevalence of primary glaucoma in an south Indian population. Ind. J. Ophthalmol., 46–86.
Jacobson, N., Andrews, M., Shepard, A.R., et al. (2001) Nonsecretion of mutant proteins of the glaucoma gene, myocilin in cultured trabecular meshwork cells and in aqueous humour. Hum. Mol. Genet., 10: 117–125.
Kashiwagi, K., Abe, K. and Tsukahara, S. (2004) Quantitative evaluation of changes in anterior segment biometry by peripheral laser iridotomy using newly developed scanning peripheral anterior chamber depth analyser. Br. J. Ophthalmol., 88: 1036–1041.
Kobayashi, H., Kobayashi, K., Kiryu, J. and Kondo, T. (1999) Pilocarpine induces an increase in the anterior chamber angular width in eyes with narrow angles. Br. J. Ophthalmol., 83: 553–558.
Kumar, K.S., Baskaran, M., Chew, P.T., et al. (2008) Prevalence of plateau iris in primary angle closure suspects an ultrasound biomicroscopy study. Ophthalmology, 115: 430–434.
Lai, J.S., Liu, D.T., Tham, C.C., et al. (2001) Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study. Hong Kong Med. J., 7: 118–123.
Lai, J.S., Tham, C.C. and Chan, J.C. (2006) The clinical outcomes of cataract extraction by phacoemulisfication in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: a prospective case series. J. Glaucoma, 15: 47–52.
Lam, D.S., Tham, C.C., Lai, J.S. and Leung, D.Y. (2007) Current approaches to the management of acute primary angle closure. Curr. Opin. Ophthalmol., 18: 146–151.
Liebmann, J. (2006) In: Weinreb R.N. and Friedman D.S. (Eds.), Angle Closure and Angle Closure Glaucoma Consensus Series 3. Kugler Publications Appendix B.
Lim, L., Seah, S.K. and Lim, A.S. (1996) Comparison of argon laser iridotomy and sequential argon laser and Nd:YAG laser iridotomy in dark irides. Ophthalmic Surg. Lasers, 27: 285–288.
Lin, Y.W., Wang, T.H. and Hung, P.T. (1997) Biometric study of acute primary angle-closure glaucoma. J. Formos. Med. Assoc., 96: 908–912.
Lowe, R.F. (1964) Primary angle-closure glaucoma. Family histories and anterior chamber depths. Br. J. Ophthalmol., 48: 191–195.
Lowe, R.F. (1969) Causes of shallow anterior chamber in primary angle closure glaucoma. Ultrasonic biometry of normal and angle-closure eyes. Am. J. Ophthalmol., 67: 87–93.
Lowe, R.F. (1972) Anterior lens curvature. Comparisons between normal eyes and those with primary angle-closure glaucoma. Br. J. Ophthalmol., 56: 409–413.
Lowe, R.F. (1977) Primary angle-closure glaucoma: A review of ocular biometry. Aust. J. Ophthalmol., 5: 9–17.
Luntz, M.H. (1973) Primary angle-closure glaucoma in urbanized South African Caucasoid and Negroid communities. Br. J. Ophthalmol., 57: 445–446.
Marchini, G., Pagliarusco, A., Toscano, A., et al. (1998) Ultrasound biomicroscopic and conventional ultrasonographic study of ocular dimensions in primary angle closure glaucoma. Ophthalmology, 105: 2091–2098.
Ming Zhi, Z., Lim, A.S. and Yin Wong, T. (2003) A pilot study of lens extraction in the management of acute primary angle-closure glaucoma. Am. J. Ophthalmol., 135: 534–536.
Nolan, W.P., Foster, P.J., Devereux, J.G., et al. (2000) YAG laser iridotomy treatment for primary angle closure in East Asian eyes. Br. J. Ophthalmol., 84: 1255–1259.
Radhakrishnan, S., Goldsmith, J., Huang, D., et al. (2005) Comparison of optical coherence tomography and ultrasound biomicroscopy for detection of narrow anterior chamber angles. Arch. Ophthalmol., 123: 1053–1059.
Radhakrishnan, S., See, J., Smith, S.D., et al. (2007) Reproducibility of anterior chamber angle measurements obtained with anterior segment optical coherence tomography. Invest. Ophthalmol. Vis. Sci., 48: 1303–1306.
Ritch, R. and Lowe, R.F. (1996a) In: Ritch R., Shields M.B. and Krupin T. (Eds.), Classifications and Mechanisms of the Glaucomas, The Glaucomas (2nd edn.). Mosby, St. Louis, p 752.
Ritch, R. and Lowe, R.F. (1996b) Angle-closure glaucoma: therapeutic overview. In: Ritch R., Shields M.B. and Krupin
45
T. (Eds.), The Glaucomas (2nd edn.). Mosby, St. Louis, pp 1521–1531.
Ritch, R., Tham, C.C. and Lam, D.S. (2004) Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome. Ophthalmology, 111: 104–108.
Scheie, H.G. (1957) Width and pigmentation of the angle of the anterior chamber. A system of grading by gonioscopy. Arch. Ophthalmol., 58: 510–512.
Seah, S.K., Foster, P.J., Chew, P.T., et al. (1997) Incidence of acute angle closure glaucoma in Singapore. An island-wide survey. Arch. Ophthalmol., 115: 1436–1440.
Sihota, R., Lakshimaiah, N.C., Agrawal, H.C., et al. (2000) Ocular parameters in the subgroups of angle closure glaucoma. Clin. Exp. Ophthalmol., 28: 253–258.
South East Asia Glaucoma Interest Group website. Available at http://www.seagig.org/pdf/APGGuidelinesNMview.pdf. Accessed February 29th, 2008
Spaeth, G.L. (1971) The normal development of the human anterior chamber angle: a new system of descriptive grading. Trans. Ophthalmol. Soc. UK, 91: 709–739.
Teikari, J., Raivio, I. and Nurminen, M. (1987) Incidence of acute glaucoma in Finland from 1973 to 1982. Graefes Arch. Clin. Exp., 225: 357–360.
Tomlinson, A. and Leighton, D.A. (1973) Ocular dimensions in the heredity of angle-closure glaucoma. Br. J. Ophthalmol., 57: 475–486.
Tran, H.V., Liebmann, J.M. and Ritch, R. (2003) Iridociliary apposition in plateau iris syndrome persists after cataract extraction. Am. J. Ophthalmol., 135: 40–43.
Vijaya, L., George, R. and Arvind, H., et al. (2007) Prevalence of primary angle-closure disease in an urban South Indian population and comparison with a rural population The Chennai Glaucoma Study. Ophthalmology (Epub ahead of print).
Vincent, A.L., Billingsley, G., Buys, Y., et al. (2002) Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am. J. Hum. Genet., 70: 448–460.
Wang, I.J., Chiang, Th., Shih, Y.F., et al. (2006) The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients. Mol. Vis., 12: 1223–1232.
Wensor, M.D., Mc Carty, C.A., Stanislavsky, Y.L., et al. (1998) The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology, 105: 733–739.
Wong, T.Y., Foster, P.J., Seah, S.K. and Chew, P.T. (2000) Rates of hospital admissions for primary angle closure glaucoma among Chinese, Malays and Indians in Singapore. Br. J. Ophthalmol., 84: 990–992.
Yip, J.L.Y. and Foster, P.J. (2006) Ethnic differences in primary angle-closure glaucoma. Curr. Opin. Ophthalmol., 17: 175–180.